Trial
NCT02485353
Study of Vosaroxin and Cytarabine for the Treatment of Adults 60 Years of Age or Older With Previously Untreated AML
UnknownTERMINATEDSAFETYConfidence: MEDIUM
Sponsor
Hamid Sayar
Collaborators
—
Condition
Leukemia, Myeloid, Acute
Intervention
Vosaroxin and Cytarabine
Why stopped
Safety concerns
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-09-20